Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

101.66 +0.98 (+0.97%)
Official Closing Price Updated: 7:00 PM EDT, Jul 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
56 57 Next >
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever ↗
These companies' longtime shareholders have generally been rewarded. 
Via The Motley Fool
News headline image
MarketBeat Week in Review – 10/14 - 10/18
Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election. 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review ↗
The Dow Jones and S&P 500 hit highs as they extended weekly win streaks. 
Via Investor's Business Daily
Topics Stocks
News headline image
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now ↗
These stocks could deliver big over the long term. 
Via The Motley Fool
News headline image
Is Abbott Laboratories Stock a Buy? ↗
The healthcare stock is lagging the market this year. 
Via The Motley Fool
News headline image
Price Over Earnings Overview: Abbott Laboratories ↗
 
Via Benzinga
News headline image
Abbott Labs Earnings Edge Past Q3 Views, Led By Medical Devices ↗
Medical devices led organic sales growth. 
Via Investor's Business Daily
News headline image
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic ↗
Abbott Laboratories reported Q3 sales of $10.64 billion, driven by 8.2% organic growth in medical devices. Adjusted EPS for 2024 projected at $4.64-$4.70, with expectations of double-digit growth... 
Via Benzinga
News headline image
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings ↗
 
Via Benzinga
News headline image
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories ↗
AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says. 
Via Benzinga
News headline image
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Why Abbott Laboratories Stock Was a Winner on Wednesday ↗
Investors bumped its shares higher following a decent, if unspectacular, earnings report. 
Via The Motley Fool
News headline image
A Glimpse of Abbott Laboratories's Earnings Potential ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 9 Analysts Discuss Abbott Laboratories Stock ↗
 
Via Benzinga
News headline image
A Look Into Abbott Laboratories Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript ↗
ABT earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Tech Stocks Stall, Small Caps Surge As Regional Banks Rally, Airlines Rocket: What's Driving Markets Wednesday? ↗
Small-cap stocks outperformed large caps in Wednesday's session, with the Russell 2000 Index surging to test July 2024 highs on the back of expectations for interest rate cuts and a strong rally in... 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Abbott Laboratories? ↗
 
Via Benzinga
News headline image
Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results align with the trend. 
Via MarketBeat
News headline image
Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast ↗
Abbott Laboratories reported third-quarter 2024 sales of $10.64B, with Medical Devices leading 11.7% sales growth. Adjusted EPS of $1.21 beat analyst expectations. Full-year guidance was updated. 
Via Benzinga
News headline image
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips ↗
U.S. stock futures point to a flattish start on Wednesday after the S&P 500 Index and the Dow Jones Industrial Average retreated from record highs in the previous session. 
Via Benzinga
Topics Stocks
News headline image
Abbott Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗
 
Via Benzinga
News headline image
Nasdaq Dips 1% Amid Plunge In Chipmaker Stocks: Fear & Greed Index Moves To 'Greed' Zone ↗
 
Via Benzinga
News headline image
Morgan Stanley, Abbott Laboratories And 3 Stocks To Watch Heading Into Wednesday ↗
 
Via Benzinga
News headline image
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce ↗
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana. 
Via Talk Markets
News headline image
Columbus Day: Is Stock Market Open Today? ↗
Investors should brace for a busy week with earnings reports from major companies. 
Via Benzinga
News headline image
Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth ↗
Abbott Laboratories' MedTech portfolio currently contributes around 45% of total sales of about $42 billion. 
Via Benzinga
News headline image
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.